GSK to cap out-of-pocket inhaler costs in US | Reuters

GSK To Cap Out-of-pocket Inhaler Costs In US | Reuters

1 week from now

March 20 (Reuters) - British pharmaceutical giant GSK , opens new tab said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per ...

reuters.com

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

1 week from now

March 18 (Reuters) - Drugmaker AstraZeneca , opens new tab said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from …

reuters.com

GSK To Cap Out-of-pocket Inhaler Costs In US - Yahoo

1 week from now

Mar 20, 2024  · (Reuters) -British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month …

yahoo.com

GSK Announces Cap Of $35 Per Month On U.S. Patient Out-of …

1 week from now

Mar 20, 2024  · The out-of-pocket price cap will provide a significant benefit to patients taking these medicines whose monthly costs currently exceed $35. Maya Martinez-Davis, President, …

gsk.com

GSK To Cap Out-of-pocket Inhaler Costs In US - Nasdaq

1 week from now

March 20 (Reuters) - British pharmaceutical giant GSK GSK.L said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines …

nasdaq.com

Drug Companies Step Forward With Voluntary Price Caps On Inhalers

1 week from now

June 2, 2024. Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients.. The price caps for …

allergyasthmanetwork.org

Some Drugmakers To Cap Cost Of Asthma Inhalers At $35 A Month

1 week from now

May 31, 2024  · Kiowa Rix, 27, of Warren, Michigan, found herself with a $500 out-of-pocket price tag for her son Lucas’ inhaler — Flovent, from GSK — in February, when her insurance …

nbcnews.com

GSK To Cap Out-of-pocket Inhaler Costs In US - Dunya News

1 week from now

Mar 21, 2024  · (Reuters) – British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month …

dunyanews.tv

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

1 week from now

Mar 21, 2024  · GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals …

yahoo.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

1 week from now

Mar 21, 2024  · However, GSK plans to start this in 2025. The British drugmaker is one of the biggest sellers of inhalers in the United States. Shares of GSK have gained 13.1% year to …

nasdaq.com

GSK To Cap Out-of-pocket Inhaler Costs In US - Yahoo Finance

1 week from now

Mar 20, 2024  · British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines for …

yahoo.com

GSK To Cap Out-of-pocket Inhaler Costs In US - KFGO

1 week from now

Mar 20, 2024  · (Reuters) – British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines …

kfgo.com

Now That Two Inhaler Makers Are Capping Patient Costs, Will …

1 week from now

Mar 18, 2024  · AstraZeneca’s move on Monday to cap at $35 the out-of-pocket costs that patients pay for the company’s Symbicort inhaler speaks to the political and regulatory pressure …

wsj.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US - MSN

1 week from now

GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals AstraZeneca AZN and ...

msn.com

Boehringer To Cap Out-of-pocket Inhaler Cost At $35 Per Month

1 week from now

Mar 7, 2024  · Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German …

reuters.com

Boehringer To Cap Out-Of-Pocket Inhaler Cost At $35 Per Month

1 week from now

Mar 7, 2024  · (Reuters) -Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the …

usnews.com

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

1 week from now

Mar 21, 2024  · GSK plc (GSK Quick Quote GSK - Free Report) announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, …

zacks.com

AstraZeneca To Cap Out-Of-Pocket Inhaler Costs In US, Following …

1 week from now

Mar 18, 2024  · (Reuters) -Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, …

usnews.com

AstraZeneca (AZN) Follows Boehringer, To Cap Inhaler Cost In US

1 week from now

Mar 19, 2024  · AstraZeneca AZN announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rival …

nasdaq.com